openPR Logo
Press release

Pharmacovigilance (PV) Market With Covid-19 Impact and Market Size, Share, Growth Factors, Competitive Landscape and Regional Forecast 2031 | Linical Accelovance, Cognizant, IBM Corporation, ArisGlobal

05-02-2023 07:32 AM CET | Industry, Real Estate & Construction

Press release from: Global Insight Services

Pharmacovigilance (PV) Market

Pharmacovigilance (PV) Market

New York, According to a new market research report published by Global Insight Services Pharmacovigilance (PV) Market is expected to grow by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS22087

Pharmacovigilance is the science and activities related to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.

Passive surveillance is the most common type of pharmacovigilance activity. It is important because it can identify previously unknown adverse events. However, it has some limitations, such as under-reporting and reporting bias.

Active surveillance is less common, but it is useful for monitoring drugs that are used to treat rare conditions. Experimental studies are the most reliable way to assess the safety of a new medicine, but they are usually only conducted during the development and approval process.

Key Trends

There are several key trends in PV technology:

1. The use of big data and machine learning to identify potential safety risks.

2. The use of predictive analytics to identify at-risk patients.

3. The use of social media monitoring to identify potential safety concerns.

4. The use of mobile technology to collect patient-reported data.

Key Drivers

The key drivers of pharmacovigilance (PV) market are the increasing number of clinical trials, the growing prevalence of chronic and life-threatening diseases, and the need for better patient safety.

The number of clinical trials has been increasing over the years as the pharmaceutical industry seeks to develop new and better treatments for various diseases. This has led to an increase in the number of patients being exposed to new drugs, which has in turn led to an increase in the need for PV.

The prevalence of chronic and life-threatening diseases is also a key driver of the PV market. As the population ages, the number of people suffering from chronic diseases such as cancer and heart disease is increasing. This is leading to a greater need for PV, as these patients are often taking multiple medications that need to be closely monitored for safety.

Read Full Research Report : https://www.globalinsightservices.com/reports/pharmacovigilance-pv-market

Key Market Segments

The pharmacovigilance (PV) bifurcated on the basis of type, service provider, end-user, and region. On the basis of type, it is segmented into adverse drug reaction capture (ADR), case processing, reporting & submission, and others. By service provider, it is divided into up to contract research organization and business processing outsourcing. By end-user, it is analyzed across pharmaceutical industry, research organization, and others. Region-wise, it is studied across North America, Europe, Asia-Pacific, and rest of the World.

Key Market Players

The pharmacovigilance (PV) market report includes players such as Linical Accelovance, Cognizant, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, and IQVIA.

Buy Now : https://www.globalinsightservices.com/checkout/single_user/GIS22087

Reasons to buy Pharmacovigilance (PV) Market Report:

• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market

New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacovigilance (PV) Market With Covid-19 Impact and Market Size, Share, Growth Factors, Competitive Landscape and Regional Forecast 2031 | Linical Accelovance, Cognizant, IBM Corporation, ArisGlobal here

News-ID: 3036493 • Views:

More Releases from Global Insight Services

RFID Printers Market rising from $1.8 Bn to $3.2 Bn (2034), CAGR 5.9%. Key Players: SATO Holdings, TSC Printronix Auto ID, Zebra Technologies
RFID Printers Market rising from $1.8 Bn to $3.2 Bn (2034), CAGR 5.9%. Key Playe …
Market Overview RFID Printers Market is witnessing rapid growth as industries increasingly adopt advanced identification and tracking solutions. RFID (Radio Frequency Identification) printers enable organizations to encode and print data on RFID tags, revolutionizing asset tracking, inventory management, and supply chain operations. This technology supports key sectors such as retail, healthcare, logistics, and manufacturing, allowing seamless data capture and real-time visibility. As digital transformation accelerates globally, the RFID Printers Market is
PVC Coated Woven Fabrics Market to grow from $3.5 Bn (2024) to $6.8 Bn (2034) at 6.9% CAGR. Key Players: Sioen Industries, Mehler Texnologies, Serge Ferrari Group
PVC Coated Woven Fabrics Market to grow from $3.5 Bn (2024) to $6.8 Bn (2034) at …
Market Overview PVC Coated Woven Fabrics Market is experiencing significant growth, driven by increasing demand for durable, water-resistant, and versatile materials across various industries. These fabrics, coated with polyvinyl chloride, offer exceptional strength, flexibility, and weather resistance, making them ideal for use in automotive interiors, industrial tarpaulins, construction materials, and outdoor furniture. As industries worldwide prioritize sustainability and performance, the PVC Coated Woven Fabrics Market is witnessing a surge in innovative
Thermoelectric Generators Market Expected to Grow from $0.7 Billion in 2024 to $1.6 Billion by 2034 at 8.6% CAGR | Overall Study Report
Thermoelectric Generators Market Expected to Grow from $0.7 Billion in 2024 to $ …
The Thermoelectric Generators Market is witnessing significant growth as industries and governments worldwide push for cleaner, more sustainable energy solutions. Thermoelectric generators (TEGs) are devices that convert heat differentials directly into electricity, providing an efficient and eco-friendly alternative to conventional power generation methods. The market spans multiple sectors, including automotive, aerospace, industrial, and consumer electronics, where TEGs are employed for waste heat recovery and energy efficiency optimization. Rising environmental concerns,
Software Defined Radio Market Expected to Grow from $20.8 Billion in 2024 to $45.2 Billion by 2034 at 8.3% CAGR | Overall Study Report
Software Defined Radio Market Expected to Grow from $20.8 Billion in 2024 to $45 …
The Software Defined Radio Market is poised for remarkable growth over the coming decade, driven by increasing demand for flexible and efficient communication systems. Software Defined Radio (SDR) technology replaces traditional hardware-based radio components with software-based solutions, enabling seamless upgrades, multi-standard support, and cost-efficient operations. The market spans diverse sectors including defense, aerospace, telecommunications, and public safety. Its versatility in signal processing makes SDR an essential tool for industries seeking

All 5 Releases


More Releases for Pharmacovigilance

Top Pharmacovigilance Companies Analysis By 2031
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpenPR&utm_medium=10379 The List of Companies • #Accentures • Bristol-Myers Squibb Company • Linical Accelovance • Cognizant • Covance Inc. • F. Hoffmann-La Roche Ltd. • GlaxoSmithKline plc. • ICON plc • Capgemini (IGATE Corporation) Clinical
Pharmacovigilance - Scope and Research Methodology
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. The Pharmacovigilance Market report covers analysis by Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-House and Contract Outsourcing), Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event
Pharmacovigilance World 2025 Conference & Expo
We are delighted to welcome you to the Pharmacovigilance World 2025, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide. As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes
Top Factor Driving Pharmacovigilance Market Growth in 2025: Research And Develop …
How Are the key drivers contributing to the expansion of the pharmacovigilance market? The escalation in research and development undertakings stimulates growth in the pharmacovigilance market. Pharmaceutical organizations can create novel and superior drugs through enhanced safety profiles by allocating resources to R&D. The intensive testing in preclinical and clinical stages during the drug development protocol allows early recognition of potential safety issues, paving the way for adequate risk reduction approaches.
Monitoring Medication Safety with Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications. Download Sample PDF at: https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpnePR&utm_medium=10776 Increasing cases of adverse drug reactions
Pharmacovigilance Market Opportunity Analysis by 2028
Pharmacovigilance Market: Introduction According to the report, the global pharmacovigilance market was valued at US$ 6.1 Bn in 2020 and is projected to expand at a CAGR of 8.8% from 2021 to 2028. Pharmacovigilance activities are defined as science used for detection, assessment, understanding, and prevention of adverse effects of drugs and vaccines. Drugs and vaccines go through rigorous testing in the clinical trials to check their safety and efficacy before